Clinical Trial: Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive Bladder

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07773532) titled 'Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive Bladder' on Aug. 15.

Brief Summary: Overactive bladder (OAB) is associated with systemic chronic inflammation. Indices derived from complete blood count (such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII)) have shown associations with OAB presence. However, whether baseline inflammatory status predicts response to beta-3 adrenergic agonist therapy remains untested. This prospective observational cohort study evaluates the predictive ability of baseline NLR, PLR, and ...